Colgate-Palmolive (NYSE:CL) Shares Bought by Southland Equity Partners LLC

Southland Equity Partners LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 26.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,881 shares of the company’s stock after purchasing an additional 813 shares during the period. Southland Equity Partners LLC’s holdings in Colgate-Palmolive were worth $353,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cornerstone Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 8.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 8,925 shares of the company’s stock worth $811,000 after acquiring an additional 699 shares in the last quarter. Brighton Jones LLC boosted its stake in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares in the last quarter. Montecito Bank & Trust boosted its stake in shares of Colgate-Palmolive by 9.0% during the 4th quarter. Montecito Bank & Trust now owns 12,320 shares of the company’s stock worth $1,120,000 after acquiring an additional 1,018 shares in the last quarter. Apeiron RIA LLC boosted its stake in shares of Colgate-Palmolive by 5.1% during the 4th quarter. Apeiron RIA LLC now owns 7,745 shares of the company’s stock worth $704,000 after acquiring an additional 379 shares in the last quarter. Finally, Whalen Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $291,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.34% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Finally, Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $87.98 on Friday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm’s 50-day moving average price is $92.00 and its two-hundred day moving average price is $97.58. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The stock has a market capitalization of $71.88 billion, a P/E ratio of 25.21, a P/E/G ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.